|
Danazol
|
Antigonadotropic agents
|
13-Aug-2023 |
|
Damiana
|
Herbal products
|
13-Aug-2023 |
|
Dalteparin
|
Heparins
|
13-Aug-2023 |
|
Dalfopristin and quinupristin
|
Streptogramins
|
13-Aug-2023 |
|
Dalfampridine
|
Miscellaneous central nervous system agents
|
13-Aug-2023 |
|
Dalbavancin
|
Glycopeptide antibiotics
|
13-Aug-2023 |
|
Daily fiber sugar-free
|
Laxatives
|
13-Aug-2023 |
|
Dactinomycin
|
Antibiotics / antineoplastics
|
13-Aug-2023 |
|
Dacomitinib
|
EGFR inhibitors
|
13-Aug-2023 |
|
Cytomegalovirus immune globulin iv (monograph)
|
Drugs
|
13-Aug-2023 |
|
Cytomegalovirus immune globulin (cmv ig) (injection)
|
Immune globulins
|
13-Aug-2023 |
|
Cytisine
|
Drugs
|
13-Aug-2023 |
|
Cytarabine and daunorubicin (liposomal)
|
Antineoplastic combinations
|
13-Aug-2023 |
|
Cytarabine
|
Antimetabolites
|
13-Aug-2023 |
|
Cysteamine ophthalmic
|
Miscellaneous ophthalmic agents
|
13-Aug-2023 |
|
Cysteamine hydrochloride (monograph)
|
Drugs
|
13-Aug-2023 |
|
Cysteamine bitartrate (monograph)
|
Drugs
|
13-Aug-2023 |
|
Cysteamine
|
Miscellaneous uncategorized agents
|
13-Aug-2023 |
|
Cyproheptadine
|
Antihistamines
|
13-Aug-2023 |
|
Cyclosporine (systemic) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Cyclosporine (eent) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Cyclosporine (oral/injection)
|
Calcineurin inhibitors
|
13-Aug-2023 |
|
Cyclosporine ophthalmic
|
Ophthalmic anti-inflammatory agents
|
13-Aug-2023 |
|
Cycloserine
|
Streptomyces derivatives
|
13-Aug-2023 |
|
Cyclophosphamide (oral and injection)
|
Alkylating agents
|
13-Aug-2023 |
|
Cyclopentolate ophthalmic
|
Mydriatics
|
13-Aug-2023 |
|
Cyclopentolate and phenylephrine ophthalmic
|
Mydriatics
|
13-Aug-2023 |
|
Benzoyl peroxide and clindamycin topical
|
Topical acne agents
|
13-Aug-2023 |
|
Benzocaine topical
|
Topical anesthetics
|
13-Aug-2023 |
|
Benzocaine (eent) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Benzethonium chloride topical
|
Antiseptic and germicides
|
13-Aug-2023 |
|
Benznidazole
|
Miscellaneous antibiotics
|
13-Aug-2023 |
|
Benralizumab (systemic) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Benralizumab
|
Interleukin inhibitors
|
13-Aug-2023 |
|
Bendroflumethiazide and nadolol
|
Beta blockers with thiazides
|
13-Aug-2023 |
|
Bendamustine
|
Alkylating agents
|
13-Aug-2023 |
|
Benadryl children's dye free
|
Anticholinergic antiemetics
|
13-Aug-2023 |
|
Bempedoic acid and ezetimibe
|
Antihyperlipidemic combinations
|
13-Aug-2023 |
|
Bempedoic acid
|
Miscellaneous antihyperlipidemic agents
|
13-Aug-2023 |
|
Belzutifan
|
Miscellaneous antineoplastics
|
13-Aug-2023 |
|
Belumosudil
|
Selective immunosuppressants
|
13-Aug-2023 |
|
Belladonna tincture
|
Anticholinergics / antispasmodics
|
13-Aug-2023 |
|
Belladonna and opium (rectal)
|
Narcotic analgesic combinations
|
13-Aug-2023 |
|
Belladonna alkaloids and phenobarbital
|
Anticholinergics / antispasmodics
|
13-Aug-2023 |
|
Belladonna
|
Anticholinergics / antispasmodics
|
13-Aug-2023 |
|
Belinostat
|
Histone deacetylase inhibitors
|
13-Aug-2023 |
|
Belimumab
|
Selective immunosuppressants
|
13-Aug-2023 |
|
Belatacept
|
Selective immunosuppressants
|
13-Aug-2023 |
|
Belantamab mafodotin
|
Miscellaneous antineoplastics
|
13-Aug-2023 |
|
Bee pollen
|
Herbal products
|
13-Aug-2023 |
|
Bedaquiline
|
Diarylquinolines
|
13-Aug-2023 |
|
Beclomethasone nasal
|
Nasal steroids
|
13-Aug-2023 |
|
Beclomethasone inhalation
|
Inhaled corticosteroids
|
13-Aug-2023 |
|
Beclomethasone (systemic, oral inhalation) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Beclomethasone (eent) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Avibactam and ceftazidime
|
Cephalosporins / beta-lactamase inhibitors
|
13-Aug-2023 |
|
Avelumab
|
Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
|
13-Aug-2023 |
|
Avedana hydrocortisone with aloe
|
Topical steroids
|
13-Aug-2023 |
|
Avatrombopag
|
Platelet-stimulating agents
|
13-Aug-2023 |
|
Avapritinib
|
Multikinase inhibitors
|
13-Aug-2023 |
|
Avanafil
|
Impotence agents
|
13-Aug-2023 |
|
Atropine ophthalmic
|
Mydriatics
|
13-Aug-2023 |
|
Atropine (injection)
|
Anticholinergic chronotropic agents
|
13-Aug-2023 |
|
Atropine and pralidoxime
|
Antidotes
|
13-Aug-2023 |
|
Atropine and diphenoxylate
|
Antidiarrheals
|
13-Aug-2023 |
|
Atropine (eent) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Atracurium (monograph)
|
Drugs
|
13-Aug-2023 |
|
Atovaquone and proguanil
|
Antimalarial combinations
|
13-Aug-2023 |
|
Atovaquone
|
Miscellaneous antibiotics
|
13-Aug-2023 |
|
Athlete's foot cream
|
Topical antifungals
|
13-Aug-2023 |
|
Atezolizumab
|
Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
|
13-Aug-2023 |
|
Atenolol and chlorthalidone
|
Beta blockers with thiazides
|
13-Aug-2023 |
|
Aspirin, carisoprodol, and codeine
|
Skeletal muscle relaxant combinations
|
13-Aug-2023 |
|
Aspirin, chlorpheniramine, and phenylephrine
|
Upper respiratory combinations
|
13-Aug-2023 |
|
Aspirin, caffeine, and orphenadrine
|
Skeletal muscle relaxant combinations
|
13-Aug-2023 |
|
Aspirin, butalbital, caffeine, and codeine
|
Narcotic analgesic combinations
|
13-Aug-2023 |
|
Aspirin, butalbital, and caffeine
|
Analgesic combinations
|
13-Aug-2023 |
|
Aspirin (rectal)
|
Platelet aggregation inhibitors
|
13-Aug-2023 |
|
Aspirin and omeprazole
|
Platelet aggregation inhibitors
|
13-Aug-2023 |
|
Aspirin and dipyridamole
|
Platelet aggregation inhibitors
|
13-Aug-2023 |
